Table 1.
Definitions.
Figure 1.
Study group flowchart.
Table 2.
Baseline characteristic of the study subjects according to vaccine group.
Table 3.
Antibody responses according to vaccine groups.
Figure 2.
Evolution of geometric mean titers in the four vaccine groups over time.
The trends over time for geometric mean titers in the vaccine groups were not significantly different using general estimating equations.
Figure 3.
Evolution of sero-conversion rate (as percentage) in women in the four vaccine groups over time.
The trends over time for the number of women sero-converted were not significantly different. The number of non-pregnant women (NPa7.5 µg) who sero-converted was 2.48-fold higher than among pregnant (Pa7.5 µg) women using general estimating equations.
Table 4.
Solicited local reactions the first 3 weeks following vaccination.
Table 5.
Solicited systemic reactions the first 3 weeks following vaccination.